Nature Medicine

Crispr Therapeutics AG (NASDAQ: CRSP) plunged more than 14 percent Monday after Nature Medicine published two studies warning that CRISPR-Cas9 might actually trigger cancer rather than treat targeted diseases. The research was separately reported by the Karolinska Institute and Novartis AG (ADR) (...